Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a publicly traded Healthcare sector company. As of August 19, 2026, AMRX trades at $18.82 with a market cap of $6.42B and a P/E ratio of 80.85. AMRX moved +3.47% today. Year to date, AMRX is +44.37%; over the trailing twelve months it is +96.44%. Its 52-week range spans $6.69 to $19.26. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces AMRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AMRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $18.82 |
| Market Cap | $6.42B |
| P/E Ratio | 80.85 |
| EPS | $0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.26 |
| 52-Week Low | $6.69 |
| Volume | 65 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.02B |
| Net Income | $127.93M |
| Gross Margin | 36.88% |
4 analysts cover AMRX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.